生命科学资讯

Aardvark pauses phase 3 metabolic drug study over 'cardiac observations,' sinking sock

Roche reports another phase 3 multiple sclerosis win, but deaths add to safety questions

Quantbot Technologies LP Takes $4.23 Million Position in Waters Corporation $WAT - MarketBeat

Mitsubishi UFJ Asset Management Co. Ltd. Grows Stake in Waters Corporation $WAT - MarketBeat

Why it’s critical to close open steps in cell therapy manufacturing

Davis R M Inc. Sells 2,494 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Inventerprise celebrates student winners in Bend - Central Oregon Daily

Agent-based modeling reveals how bats navigate dense group emergences

Resolving synaptic events using subsynaptically targeted GCaMP8 variants

A sense of direction

Agilent Technologies Inc.: Why This Lab-Tech Giant Is Suddenly on Every Trader’s Radar - AD HOC NEWS

10X Genomics Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo

10X Genomics Hits Day High with Strong 12.56% Intraday Surge - Markets Mojo

William Blair Investment Management LLC Has $275.19 Million Stake in Agilent Technologies, Inc. $A - MarketBeat

Erste Asset Management GmbH Grows Stock Holdings in Waters Corporation $WAT - MarketBeat

Is It Time To Reassess 10x Genomics (TXG) After Its 1 Year Share Price Surge - Yahoo Finance

Agilent (A) Gets Lower Goldman Sachs Target Despite Long-Term Growth Confidence - Finviz

Thermo Fisher’s TacroType Test Highlights Push Into Targeted Transplant Genomics - simplywall.st

Illumina Deepens Clinical Genomics Role With TruPath Genome And FSU Deal - simplywall.st

Lonza Group AG Stock: Quiet Swiss Giant, Big US Biotech Play - AD HOC NEWS